(Press-News.org) A new study helps to resolve an ongoing controversy about whether Langerhans cells (LCs) in human skin function to suppress the immune response and promote tolerance to normal human skin and its "friendly" microbial flora or mobilize a lethal attack against harmful foreign invaders. The research, published online May 3rd in the journal Immunity by Cell Press, reveals that, depending on the situation, these versatile immune cells can perform either function.
Adult human skin contains billions of resident immune cells called T cells that provide protection from invading pathogens. Skin also contains LCs, which reside in the outermost layer of skin, the epidermis. LCs are known to interact with T cells and are traditionally considered to be the first line of defense against invading pathogens. However, previous studies have provided conflicting results about the specific function of LCs. Also, until now, it has been difficult to characterize the role of LCs in human skin, primarily because much of the research has been done using mouse models and there appear to be significant differences between LCs in mouse and human skin.
"There is substantial controversy surrounding the role of LCs with regards to whether they serve to stimulate the immune response upon encountering an invading pathogen or whether they play a more immunomodulatory role and induce tolerance in normal skin," explains senior study author, Dr. Thomas S. Kupper from Brigham and Women's Hospital and the Harvard Skin Disease Research Center. Taking advantage of a significant technical advance in the ability extract large numbers of specific immune cells from human skin, Dr. Kupper and colleagues examined the function of LCs under normal conditions and in the presence of a pathogen.
Interestingly, the researchers found that LCs interact with two different types of skin resident T cells. Under normal conditions, LCs induced proliferation of "regulatory" T cells that helped to prevent the immune system from attacking normal skin. In the presence of a pathogen, the LCs stimulated another type of T cell that mediates protective immunity. "Essentially, this means that LCs can apply the brakes to the immune response and maintain tolerance under normal conditions, but also have the capacity to push the gas and activate protective skin-resident T cells to mount an immune response when confronted with potentially harmful invaders," concludes Dr. Kupper. "This context-specific response is perfectly suited to a cell like the LC which is at the interface of the body and the environment."
###
Seneschal et al.: "Human Epidermal Langerhans Cells Maintain Immune Homeostasis in Skin by Activating Skin Resident Regulatory T Cells."
Double duty: Versatile immune cells play dual roles in human skin
2012-05-04
ELSE PRESS RELEASES FROM THIS DATE:
Treatment guidelines updated for aneurysmal subarachnoid hemorrhage
2012-05-04
Treatment guidelines updated for aneurysmal subarachnoid hemorrhage Patients who are diagnosed in the emergency room with a specific type of brain bleed should be considered for immediate transfer to a hospital that treats at least 35 cases a year, according to a new scientific statement from the American Heart Association/American Stroke Association.
The Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage (aSAH) is published online in Stroke, an American Heart Association Journal. It updates guidelines issued in 2009.
"Admission to high-volume centers ...
Pleasure eating triggers body's reward system and may stimulate overeating
2012-05-04
When eating is motivated by pleasure, rather than hunger, endogenous rewarding chemical signals are activated which can lead to overeating, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). The phenomenon ultimately affects body mass and may be a factor in the continuing rise of obesity.
"'Hedonic hunger' refers to the desire to eat for pleasure, and to enjoy the taste, rather than to restore the body's energy needs,"says Palmiero Monteleone, MD, of the University of Naples SUN in Italy ...
Some women may be genetically predisposed to smoking-related hot flashes
2012-05-04
Women who smoke and carry specific variations in the genes that impact their metabolism are at higher risk of developing hot flashes in comparison with smokers who do not carry these gene variants, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology and Metabolism (JCEM).
Previous studies have shown that smoking is associated with earlier onset of menopause, increased odds of hot flashes and risk of postmenopausal osteoporosis. The current study aimed to explore which smokers have the highest risk of hot flashes ...
Measuring progesterone receptor expression to improve hormone-receptor-positive cancer management
2012-05-04
American and Spanish researchers have found potential ways for doctors to improve the treatment of hormone receptor-positive breast cancer even if they lack access to costly multi-gene tests, as they report at the 4th IMPAKT Breast Cancer Conference.
Because breast cancer is a biologically and clinically varied disease, doctors aim to choose appropriate treatments based on the characteristics of each patient's individual tumor. In the past, this has been done using pathology-based biomarkers; however these do not capture the full diversity of cancers.
"In this context, ...
Hormone may help predict tubal ectopic pregnancy
2012-05-04
Tubal ectopic pregnancy (TEP) is currently the leading cause of pregnancy-related deaths during the first trimester and a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) shows that the hormone adrenomedullin (ADM) may help predict this condition.
TEP is a condition where the fertilized egg implants in the fallopian tubes instead of in the uterus. In pregnant women, cilia (small protuberances) pulsate, or beat, to propel an embryo through the fallopian tubes towards the uterus. Defects in ciliary beats ...
New data improve understanding of breast cancer's multiple varieties
2012-05-04
New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers.
Focused on the biological features that make tumors more or less sensitive to important therapies, the new studies will help doctors make crucial choices about the most appropriate treatment for millions of patients.
"Despite major advances in the treatment of breast cancer many patients continue to relapse and die from the disease," noted Prof Mitch Dowsett from the Royal Marsden Hospital, ...
Identifying patients who benefit most from immune suppressant
2012-05-04
A new analysis may help doctors identify breast cancer patients who will benefit from treatment with the immune suppressant drug everolimus, say French researchers at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Everolimus is currently used as an immunosuppressant to prevent patients rejecting transplanted organs and in the treatment of renal cell cancer. Research is also being conducted into the drug's use in other cancers, including breast cancer.
Dr Thomas Bachelot, from Centre Leon Berard in Lyon and colleagues analyzed data from the TAMRAD study, ...
Immune-response genes affecting breast tumor eradication
2012-05-04
Breast cancer patients whose tumors express high levels of genes related to immune response are more likely to have their tumor completely eradicated by pre-operative chemotherapy compared to patients with low expression of these genes, Belgian researchers report at the 4th IMPAKT Breast Cancer Conference in Brussels, Belgium.
Their research has identified a group of patients who might be good candidates for treatments with new immune-targeting therapies.
Dr Michail Ignatiadis from Institut Jules Bordet, Brussels, and colleagues analyzed gene expression data from eight ...
Breast cancer in young women: A distinct disease
2012-05-04
Breast cancer in young women is a biologically unique disease that requires customized management strategies, researchers report at the 4th IMPAKT Breast Cancer Conference, in Brussels, Belgium.
The reported findings have potentially important implications for treatment, because breast cancer in young women is often aggressive and diagnosed at an advanced stage, meaning the prognosis for these patients is often poor.
Dr. Hatem A. Azim Jr., a medical oncologist from Institut Jules Bordet in Brussels, and colleagues showed that breast cancer in women forty-years or younger ...
Stem cells poised to self-destruct for the good of the embryo
2012-05-04
CHAPEL HILL, N.C. – Embryonic stem cells — those revered cells that give rise to every cell type in the body — just got another badge of honor. If they suffer damage that makes them a threat to the developing embryo, they swiftly fall on their swords for the greater good, according to a study published online May 3, 2012 in the journal Molecular Cell.
The finding offers a new glimpse into the private lives of stem cells that could help scientists use them to grow new neurons or other cells to replace those that have been lost in patients with Parkinson's and other diseases. ...